Prelude Capital Management’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Prelude Capital Management’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-171,958	Closed	-$1.54M	–	2018
2016 Q3	$1.54M	Buy	171,958 +157,458	+1,086%	+$1.12M	0.16%	140
2016 Q2	$78K	Buy	14,500 +4,035	+39%	+$20.7K	0.01%	850
2016 Q1	$48K	Sell	10,465 -235	-2%	-$945	0.01%	984
2015 Q4	$56K	Buy	+10,700	New	+$62.1K	0.01%	1020
2015 Q3	–	Sell	-4,300	Closed	-$68K	–	2113
2015 Q2	$68K	Buy	4,300 +2,300	+115%	+$27.9K	0.01%	1043
2015 Q1	$22K	Buy	+2,000	New	+$20.4K	﹤0.01%	1728
2014 Q1	–	Sell	-1,992	Closed	-$28.8K	–	2364
2013 Q4	$26K	Hold	1,992	–	–	﹤0.01%	1301
2013 Q3	$30K	Sell	1,992 -3,008	-60%	-$36K	﹤0.01%	1156
2013 Q2	$47K	Buy	+5,000	New	+$33.9K	0.01%	839

Prelude Capital Management's RPTP Position: Q4 2016 in Review

Prelude Capital Management sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 171,958 shares — an estimated $1.54M sold.

Prelude Capital Management first reported a position in RPTP in Q2 2013 and held it in 9 quarters. The position peaked at $1.54M in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

Prelude Capital Management reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
Prelude Capital Management sold 171,958 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $1.54M.
Prelude Capital Management first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 9 quarters.
Prelude Capital Management's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $1.54M in Q3 2016.
0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Prelude Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.